Two maize Kip-related proteins differentially interact with, inhibit and are phosphorylated by cyclin D–cyclin-dependent kinase complexes

Autor: Silvia K. Godínez-Palma, Elpidio García-Ramírez, Omar G. Rosas-Bringas, Jorge Zamora-Zaragoza, Fernando R. Rosas-Bringas, Jorge M. Vázquez-Ramos
Rok vydání: 2017
Předmět:
Zdroj: Journal of Experimental Botany, 68(7), 1585-1597
Journal of Experimental Botany 68 (2017) 7
Journal of Experimental Botany
ISSN: 1460-2431
0022-0957
DOI: 10.1093/jxb/erx054
Popis: Highlight Maize Kip-related proteins can be differentially phosphorylated by different cyclin D–cyclin-dependent kinase complexes and this influences their performance as cyclin-dependent kinase inhibitors.
The family of maize Kip-related proteins (KRPs) has been studied and a nomenclature based on the relationship to rice KRP genes is proposed. Expression studies of KRP genes indicate that all are expressed at 24 h of seed germination but expression is differential in the different tissues of maize plantlets. Recombinant KRP1;1 and KRP4;2 proteins, members of different KRP classes, were used to study association to and inhibitory activity on different maize cyclin D (CycD)–cyclin-dependent kinase (CDK) complexes. Kinase activity in CycD2;2–CDK, CycD4;2–CDK, and CycD5;3–CDK complexes was inhibited by both KRPs; however, only KRP1;1 inhibited activity in the CycD6;1–CDK complex, not KRP4;2. Whereas KRP1;1 associated with either CycD2;2 or CycD6;1, and to cyclin-dependent kinase A (CDKA) recombinant proteins, forming ternary complexes, KRP4;2 bound CDKA and CycD2;2 but did not bind CycD6;1, establishing a differential association capacity. All CycD–CDK complexes included here phosphorylated both the retinoblastoma-related (RBR) protein and the two KRPs; interestingly, while KRP4;2 phosphorylated by the CycD2;2–CDK complex increased its inhibitory capacity, when phosphorylated by the CycD6;1–CDK complex the inhibitory capacity was reduced or eliminated. Evidence suggests that the phosphorylated residues in KRP4;2 may be different for every kinase, and this would influence its performance as a cyclin–CDK inhibitor.
Databáze: OpenAIRE